The clinician should closely monitor kidney and liver function in patients with hepatic or renal insufficiency and begin with a reduced dose. The effects of the medication may increase in patients with these medical conditions, thus increasing the chance of adverse effects.

Patients with a history of cardiac arrhythmias or coronary artery disease (CAD) using inhalation solution should undergo cardiac follow-up due to the contents of metered-dose inhaler propellants.

Regular eye examinations are necessary when using cromolyn sodium ophthalmic solution.

For individuals diagnosed with bronchial asthma, symptomatic improvement should have an assessment via pulmonary function tests.

Symptoms may reoccur when tapering or withdrawing the drug.